Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Enzyme inactivation by chemical treatment
Patent
1997-05-15
1999-10-19
Witz, Jean C.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Enzyme inactivation by chemical treatment
435219, 514569, 562405, C12N 999, C12N 950, A01N 3710, C07C 6300
Patent
active
059687959
ABSTRACT:
Matrix metalloprotease inhibiting compounds, pharmaceutical compositions thereof and a method of disease treatment using such compounds are presented. The compounds of the invention have the generalized formulas: ##STR1## where R.sup.15 is selected from the group comprising: HOCH.sub.2, (n--Pr).sub.2 NCH.sub.2, CH.sub.3 CO.sub.2 CH.sub.2, EtOCO.sub.2 CH.sub.2, HO(CH.sub.2).sub.2, CH.sub.3 CO.sub.2 (CH.sub.2).sub.2, HO.sub.2 C(CH.sub.2).sub.2, OHC(CH.sub.2).sub.3, HO(CH.sub.2).sub.4, 3--HO--Ph, and PhCH.sub.2 OCH.sub.2 ; and R.sup.16 is ##STR2## These compounds are useful for inhibiting matrix metalloproteases and, therefore, combating conditions to which MMP's contribute, such as osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses, osteopenias mediated by MMP activity, tempero mandibular joint disease, demyelating diseases of the nervous system, tumor metastasis or degenerative cartilage loss following traumatic joint injury, and coronary thrombosis from athrosclerotic plaque rupture. The present invention also provides pharmaceutical compositions and methods for treating such conditions.
REFERENCES:
patent: 3784701 (1974-01-01), Tomcufcik et al.
patent: 4801603 (1989-01-01), Souda et al.
patent: 5789434 (1998-08-01), Kluender et al.
Child, et al., A New Non-steroidal Anti-inflammatory Analgesic: .gamma.-Oxo(1,1'-biphenyl)-4-butanoic Acid (Fenbufen), Arzneim.-Forsch., 30(4A), 695-702 (1980).
Child, et al., Fenbufen, a New Anti-imflammatory Analgesic: Synthesis and Structure-Activity Relationships of Analogs, Journal of Pharmaceutical Sciences, 66(4), 466-476 (1977).
Chiccarelli, et al., Disposition and Metabolism of Fenbufen in several Laboratory Animals, Arzneim.-Forsch., 30(4A), 707-715 (1980).
Chen Jinshan
Dixon Brian R.
Bayer Corporation
Hanley Susan
Witz Jean C.
LandOfFree
Biaryl acetylenes as inhibitors of matrix metalloproteases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biaryl acetylenes as inhibitors of matrix metalloproteases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaryl acetylenes as inhibitors of matrix metalloproteases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2054786